Johnson & Johnson, McKesson Corp., AmerisourceBergen Corp, and Cardinal Health proceed with $26 billion Settlement with States to Resolve to Resolve Opioid Claims September 4, 2021
Cornerstone Research 2020 Report Identifies Trends In Securities Litigation Filings Affecting Life Sciences Firms March 5, 2021
Year-End NERA Report Shows COVID-19-Related Federal Securities Litigation Disproportionately Targeting Life Sciences Firms February 1, 2021
S.D.N.Y. Rejects Proposed Amended Complaint Alleging Manufacturer Of Liver Disease Drug Intended To Commit Fraud By Not Disclosing Serious Adverse Events September 21, 2020
Mid-Year NERA Report Shows COVID-19-Related Federal Securities Litigation Targeting Pharmaceutical Industry July 17, 2020
S.D.N.Y. Preliminarily Approves $1.6 Million Settlement in Class Action Concerning Development of an OxyContin Alternative July 17, 2020
First Circuit Affirms Dismissal of Action Regarding Statements Concerning Manufacturing of Eye Drug April 9, 2020
Cornerstone Research Report Shows Continued Rate of Federal Securities Litigation Filings Targeting Pharmaceutical Industry January 29, 2020
District Court Judge Partially Dismisses Claims Against Celgene, But Allows Allegations Regarding Misleading Statements About Sales Projections and FDA Approval to Proceed December 19, 2019
